Sunyoung KIM, D. Phil
CEO, Representative Director
-
1996~present
CEO of Helixmith
-
2014~2016
Director of National Research Council of Science & Technology (NST)
-
2013~2015
President of Seoul National University Bio-MAX Institute
-
2010~2011
Investment manager in fusion new industry sector of R&D strategy planning group, ministry of knowledge economy
-
2006~2008
The 1st and 2nd Chairman of the Korean Society of Gene Therapy
-
1992~2018
Professor, Biological Sciences, Seoul National University
-
1990~1992
Assistant Professor, Harvard Medical School
-
1987~1989
Postdoctoral fellowship, MIT Whitehead Institute
-
1986
PhD, Molecular Genetics, the University of Oxford
-
1984
Master, Microbiology/Molecular Genetics, Harvard University
-
1982
Master, Bioengineering, MIT
-
1978
BS, Microbiology, Seoul National University

Sunyoung KIM D. Phil
Seungshin Yu, Ph.D.
CTO, Representative Director
-
2020~present
CTO of Helixmith
-
2008~2019
Former Director of Bio Headquarter, President of Research Institute
-
2005~2008
Department Head, Takara Bio Research Institute
-
1995~1997
Postdoctoral fellowship, MIT Whitehead Institute
-
1984~1995
BS, Microbiology, Seoul National University, Master/Ph.D, Virology at Seoul National University

Seungshin Yu CTO
Sinyoung KIM
COO, Representative Director
-
2021~present
COO of Helixmith
-
2010~2020
CEO/Vice Chairman, Sejong Telecom Incorporated
-
2007~2010
CEO, Boas International Capital
-
2005~2007
CEO, Solomon Capital
-
2003~2005
CEO, Zionex Inc
-
1999~2002
Executive Director, Goldman Sachs Inc.
-
1998~1999
Vice President, Lone Star Funds
-
1996~1998
Director, Dongah Group
-
1983~1996
Planning Office, Samsung C&T Corp., Secretary’s Office, Samsung Group
-
1984
BS, Economics, Yonsei University
